The Cancer Vaccine
$Intismeran
About The Cancer Vaccine
The personalized mRNA therapy, called intismeran autogene, combined with Merck's Keytruda significantly boosted recurrence-free and metastasis-free survival in over 1,100 patients with resected stage IIB-IV melanoma. This marks the first Phase 3 success for a neoantigen mRNA cancer vaccine, outperforming Keytruda alone, with companies planning detailed data releases and regulator talks soon.
Project links
These destinations were supplied through the token's external market profile. Coinatio has not independently verified them. Confirm the domain and contract address before connecting a wallet or sharing information.
Contract and pair
- Contract address
- 0x6c3ea089f911e209151F6A446a599dA6c11C5C66
- Pair address
- 0xd1f38794d6d83f3325cffec82b3b22be41e2a512a24f97ae57615a93ab73472d
- Pair created
- Aug 19, 2026, 1:52 PM UTC
- Price
- $0.000214
- 24h change
- +997.00%
- Market cap
- $214.02K
- Liquidity
- $111.82K
- 24h volume
- $921.81K
- 24h trades
- 2879
Interactive market chart
Inspect the selected pair's current chart and trading activity. Verify the network and pair address before relying on the view.
Load the interactive chart
The chart is provided by an external market service. Loading it connects your browser directly to that provider.
We'll remember this choice on this device.
Market data is refreshed periodically. A listing is not an audit, endorsement, or investment recommendation.
Explore more tokens
Continue with fresh launches, active markets, and related listings.
Solana · $TRUMP